<i>Helicobacter pylori</i> infection modulates endogenous hydrogen sulfide production in gastric cancer AGS cells

Yoshinari Kawahara, Yuka Hirashita, Chikako Tamura, Yoko Kudo, Kumiko Sakai, Kazumi Togo, Kensuke Fukuda, Osamu Matsunari, Kazuhisa Okamoto, Ryo Ogawa,

Helicobacter · 2020 · 16 citations · 37 references

Concepts

Abstract

Abstract Background Persistent Helicobacter pylori infection induces gastric mucosal atrophy, which is a precancerous condition. Hydrogen sulfide (H 2 S), a gaseous biological transmitter, has been implicated in both the physiological functions of the gastrointestinal tract and its diseases. To understand gastric epithelial cell response against H pylori infection, we investigated the metabolic changes of gastric cancer cells co‐cultured with H pylori and observed the modulation of endogenous H 2 S production. Materials and Methods Gastric cancer AGS cells were co‐cultured with an H pylori standard strain possessing bacterial virulence factor CagA (ATCC 43504) and a strain without CagA (ATCC 51932). Three hours after inoculation, the cells were subjected to metabolomics analysis using gas chromatography‐tandem mass spectrometry (GC‐MS/MS). Orthogonal projections to latent structures discriminant analysis (OPLS‐DA) and pathway analysis were performed. In addition, intracellular H 2 S levels were measured by using HSip‐1 fluorescent probe. Results Results of OPLS‐DA showed a significant difference between the metabolism of untreated control cells and cells inoculated with the H pylori strains ATCC 51932 or ATCC 43504, mainly due to 45 metabolites. Pathway analysis with the selected metabolites indicated that methionine metabolism, which is related to H 2 S production, was the most frequently altered pathway. H pylori ‐inoculated cells produced more endogenous H 2 S than control cells. Moreover, ATCC 43504‐inoculated cells produced less H 2 S than ATCC 51932‐inoculated cells. Conclusions H pylori infection modulates endogenous H 2 S production in AGS cells, suggesting that H 2 S might be one of the bioactive molecules involved in the biological mechanisms of gastric mucosal disease including mucosal atrophy.

References

37